期刊文献+

中西医结合治疗急性发作期肺心病痰浊壅肺证临床研究 被引量:8

Clinical Research of Integrated Chinese and Western Medicine for Treating Pulmonary Heart Disease at Acute Attack Stage Due to Phlegm-Turbidity Obstructing the Lung Syndrome
下载PDF
导出
摘要 目的:观察中西医结合治疗急性发作期肺心病痰浊壅肺证的疗效以及对血清肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)含量的影响。方法:选择急性发作期肺心病痰浊壅肺证患者92例,按照随机数字表法分为观察组和对照组,每组各46例。所有患者均给予常规对症治疗,观察组另加用固本咳喘片治疗。结果:观察组治疗后中医临床症状评分均明显低于对照组(P<0.01);观察组有效率为91.30%,对照组有效率为71.73%,观察组明显优于对照组(P<0.05);观察组治疗后Pa CO2比对照组降低更为明显,Pa O2和心输出量较对照组明显升高(P<0.05);观察组治疗后血清TNF-α和IL-6均低于对照组(P<0.01)。结论:中西医结合治疗急性发作期肺心病痰浊壅肺证疗效显著。 Objective: To observe the efficacy of integrated Chinese and western medicine for treating pulmonary heart disease at acute attack stage due to phlegm-turbidity obstructing the lung syndrome,and the influence of it on the content of TNF-αand IL-6.Methods: 92 cases with pulmonary heart disease at acute attack stage due to phlegm-turbidity obstructing the lung syndrome were divided into observation group and control group according to the number table,with 46 cases in each group. All patients were given routine symptomatic treatment. Observation group were added with Guben Kechuan Tablets. Results: After the treatment,the TCM clinical symptom scores in observation group were significantly lower than those in control group( P 〈0. 01). The effective rate was 91. 30% in observation group and 71. 73% in control group; observation group were marked higher than control group( P 〈0. 05). The decline of Pa CO2 in observation group were much more obvious than that in control group( P 〈0. 05). The Pa CO2 and heart output quantity got apparently increased compared with control group( P 〈0. 05). The levels of serum TNF-αand IL-6 in observation group were both lower than these in control group( P 〈0. 01). Conclusion: Integrated Chinese and western medicine has remarkable therapeutic effects on pulmonary heart disease at acute attack stage due to phlegm-turbidity obstructing the lung syndrome,which can significantly improve the clinical symptoms and the levels of Pa CO2 and heart output quantity,lower the content of serum TNF-αand IL-6.
出处 《河南中医》 2015年第9期2237-2239,共3页 Henan Traditional Chinese Medicine
基金 河南省重点科技攻关计划(编号:082102310078)
关键词 肺心病 痰浊壅肺证 急性发作期 中西医结合疗法 固本咳喘片 pulmonary heart disease phlegm-turbidity obstructing the lung syndrome stage of acute attack therapy of integrated Chinese and western medicine Guben Kechuan Tablets
  • 相关文献

参考文献11

二级参考文献114

同被引文献87

  • 1乔红梅,成焕吉,尤海龙,赵凯姝,刘肖君,鲁继荣.阿奇霉素与红霉素治疗儿童肺炎支原体肺炎临床疗效对比分析[J].中华临床医师杂志(电子版),2011,5(6):1750-1752. 被引量:42
  • 2吴佩颖,徐莲英,陶建生.鱼腥草的研究进展[J].上海中医药杂志,2006,40(3):62-64. 被引量:79
  • 3武彦文,高文远,肖小河.大青叶的研究进展[J].中草药,2006,37(5):793-796. 被引量:62
  • 4王卫平.儿科学[M].8版.北京:人民卫生出版社,2013,112-114.
  • 5Patra P K, Thirunavukkarasu A B. Unusual complication of Mycoplas- ma pneumonia in a five-year-old child [J]. Australas Med J, 2013,6 (2) :73 -74.
  • 6Aviner S, Miskin H, London D, et al. Mycoplasma pneumonia Infec- tion:A Possible Trigger for Immune Thrombocytopenia [J]. Indian Journal of Hematology & Blood Transfusion,2011,27( 1 ) :46 -50.
  • 7Bressan S, Mion T, Andreola B, et al. Severe Mycoplasma pneumoni- ae-associated mucositis treated with immunoglobulins [J]. Acta Paed- iatr,2011,100 ( 11 ) :238 - 240.
  • 8Smith L G. Mycoplasma Pneumonia and Its Complications [J]. Infec- tious Disease Clinics of North America,2010,24( 1 ) :57 -60.
  • 9Biondi E, Mcculloh R, Alverson B, et al. Treatment of mycoplasma pneumonia : a systematic review [J]. Pediatrics, 2014, 133 ( 6 ) : 1081 - 1090.
  • 10韩轶,王晓峰,陈继红.沈宝藩通瘀化痰辨治肺胀经验[J].中国实验方剂学杂志,2010,16(12):224-225. 被引量:7

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部